We are live on ! Find out more
FPAS

Focus Partners Advisor Solutions Portfolio holdings

AUM $9.92B
1-Year Est. Return 21.52%
This Fund
S&P 500
This Quarter Est. Return
+8.4%
1 Year Est. Return
+21.52%
3 Year Est. Return
+51.7%
5 Year Est. Return
10 Year Est. Return
AUM
$7.49B
AUM Growth
+$915M
Cap. Flow
+$393M
Cap. Flow %
5.25%
Top 10 Hldgs %
43.02%
Holding
1,183
New
210
Increased
509
Reduced
357
Closed
84

Sector Composition

Rank Sector Weight
1 Technology 4.95%
2 Financials 2.88%
3 Healthcare 1.54%
4 Industrials 1.5%
5 Consumer Discretionary 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OXLC
1076
Oxford Lane Capital
OXLC
$830M
$47.3K ﹤0.01%
+2,250
New +$50.6K
MPT
1077
Medical Properties Trust
MPT
$2.89B
$44.1K ﹤0.01%
+10,234
New +$50.6K
BLND icon
1078
Blend Labs
BLND
$409M
$43.7K ﹤0.01%
+13,251
New +$44.9K
AMTD
1079
AMTD IDEA Group
AMTD
$75.7M
$40.1K ﹤0.01%
+40,739
New +$41.5K
RLAY icon
1080
Relay Therapeutics
RLAY
$4.02B
$38.6K ﹤0.01%
+11,162
New +$33.2K
NXDR
1081
Nextdoor Holdings
NXDR
$835M
$37.1K ﹤0.01%
+22,347
New +$33.7K
SVC
1082
Service Properties Trust
SVC
$1.1B
$35.1K ﹤0.01%
2,939
+7
+0.2% +$76
IBRX icon
1083
ImmunityBio
IBRX
$7.44B
$34.3K ﹤0.01%
13,001
+2,265
+21% +$6.09K
EDIT icon
1084
Editas Medicine
EDIT
$399M
$32.5K ﹤0.01%
14,761
+3,759
+34% +$6.15K
LPRO
1085
Open Lending Corp
LPRO
$373M
$31.8K ﹤0.01%
+16,367
New +$26.4K
RAVE icon
1086
RAVE Restaurant Group
RAVE
$44.5M
$30.3K ﹤0.01%
11,000
IRWD icon
1087
Ironwood Pharmaceuticals
IRWD
$611M
$28.5K ﹤0.01%
39,743
+29,409
+285% +$23.1K
CERS icon
1088
Cerus
CERS
$587M
$28.1K ﹤0.01%
19,930
+7,866
+65% +$10.5K
CMBM
1089
DELISTED
Cambium Networks
CMBM
$21.5K ﹤0.01%
53,186
IKT icon
1090
Inhibikase Therapeutics
IKT
$366M
$20.9K ﹤0.01%
+10,708
New +$21K
COOK icon
1091
Traeger
COOK
$170M
$20.3K ﹤0.01%
237
+8
+3% +$615
CRBU icon
1092
Caribou Biosciences
CRBU
$156M
$19.6K ﹤0.01%
15,595
+2,533
+19% +$2.49K
REI icon
1093
Ring Energy
REI
$322M
$13.5K ﹤0.01%
17,018
+2,486
+17% +$2.1K
LXRX icon
1094
Lexicon Pharmaceuticals
LXRX
$1.02B
$13K ﹤0.01%
13,746
+1,650
+14% +$1.07K
GPRO icon
1095
GoPro
GPRO
$116M
$9.85K ﹤0.01%
13,000
+1,266
+11% +$823
TNYA icon
1096
Tenaya Therapeutics
TNYA
$168M
$7.01K ﹤0.01%
+11,464
New +$5.83K
TLRY icon
1097
Tilray
TLRY
$479M
$5.76K ﹤0.01%
+1,391
New +$6.31K
ODVWZ
1098
DELISTED
Osisko Development Corp Warrant
ODVWZ
$5K ﹤0.01%
33,333
LESL icon
1099
Leslie's
LESL
$11.6M
$4.97K ﹤0.01%
+592
New +$7.79K
AA icon
1100
Alcoa
AA
$11.7B
-14,870
Closed -$454K

Similar funds

Focus Partners Advisor Solutions's Q2 2025 Portfolio in Review

As of Q2 2025, Focus Partners Advisor Solutions held 1,183 positions worth $7.49B, up 14% from $6.58B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Focus Partners Advisor Solutions deployed $393M of net new capital in Q2 2025, opening 210 new positions and adding to 509 existing holdings. Its largest new stake was iShares Broad USD High Yield Corporate Bond ETF: 401,208 shares worth $15M.

By sector, the portfolio is most concentrated in Technology at 5% of assets, up from 4.5% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Dimensional US Core Equity 2 ETF, an estimated $27.2M trimmed.

  • Focus Partners Advisor Solutions's largest Q2 2025 buy was iShares Broad USD High Yield Corporate Bond ETF: 401,208 shares worth $15M.
  • Focus Partners Advisor Solutions added most to Vanguard Total Stock Market ETF in Q2 2025, an estimated $48.9M increase.
  • Focus Partners Advisor Solutions's biggest Q2 2025 reduction was Dimensional US Core Equity 2 ETF, cutting an estimated $27.2M.
  • Focus Partners Advisor Solutions fully exited Vanguard Short-Term Tax-Exempt Bond ETF in Q2 2025, selling an estimated $4.94M.
  • Focus Partners Advisor Solutions's ten largest holdings make up 43% of its $7.49B portfolio in Q2 2025.
  • Focus Partners Advisor Solutions opened 210 new positions and closed 84 in Q2 2025.
  • Focus Partners Advisor Solutions's portfolio value rose 14% quarter-over-quarter to $7.49B.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2025, filed 31 Jul 2025.